Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep;68(7):409-410.

PURL: Antidepressant Tx for anxiety disorders: How long?

Affiliations
Comment

PURL: Antidepressant Tx for anxiety disorders: How long?

Patricia McGuire et al. J Fam Pract. 2019 Sep.

Abstract

This systematic review/meta-analysis provides some long-awaited evidence regarding the length of time to treat to minimize the risk of relapse.

PubMed Disclaimer

Comment on

References

    1. Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. Erratum in: BMJ. 2017;358:j4461. - PMC - PubMed
    1. National Institute of Mental Health. Prevalence of any anxiety disorder among adults. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder.shtml#pa.... Updated November 2017. Accessed July 11, 2019.
    1. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169–184. - PMC - PubMed
    1. Bandelow B, Sher L, Bunevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16:77–84. - PubMed
    1. Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015;17:337–346. - PMC - PubMed

Publication types

Substances